Hormone Replacement Therapy Market (By Product: Oestrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy; By Route of Administration: Oral, Parenteral, Transdermal, Others; By Indication; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030

The global hormone replacement therapy market is assessed at USD 31.4 billion in 2021 and is expected to surpass around USD 53.9 billion by 2030, developing at a CAGR of 6.4% from 2022 to 2030.

Hormone Replacement Therapy Market Size 2022 to 2030

Key Takeaways:

  • The North America region was valued at USD 10.87 billion in 2021
  • Asia Pacific region is expected to grow at a CAGR of 12.7% from 2022 to 2030
  • By product, U.S. hormone replacement therapy market was valued at USD 8.5 billion in 2021
  • In 2021, the menopause indication segment accounted largest revenue share 48%
  • In 2021, the growth hormone deficiency segment accounted market share 20%
  • Human growth hormone replacement therapy is expected to grow at a CAGR of 12.3% from 2022 to 2030
  • The parental route of administration segment accounted market share of around 41% in the 2021

Growth Factors

Hormone replacement therapy (HRT) is the therapy with hormones to supplant normal hormones when the body doesn't make enough. For example, hormone replacement therapy might be given to thyroid patients and human development hormone patients. Also, HRT was endorsed ordinarily to menopausal individuals for the help of their side effects, for example, hot flushes, night sweats, rest unsettling influences, mental and genito-urinary issues (urinary recurrence and vaginal dryness), and for the anticipation of osteoporosis. Moreover, the study of 2,000 American ladies, matured 30 to 60, viewed that as almost 47% of the overviewed populace have encountered the side effects of a hormonal lopsidedness in 2020. The central point that contributes toward the development of the worldwide hormone replacement therapy market remember ascend for commonness of menopausal problem and expansion in mindfulness about post-menopausal issues among ladies. Moreover, new send-offs of hormone replacement therapy are supposed to eminently contribute toward the hormone replacement therapy market development. Notwithstanding, unfavorable impacts of hormone replacement therapy and significant expense of therapy are expected to hamper the market development during the gauge time frame.

The COVID-19 pandemic is supposed to altogether affect the home replacement therapy market. A rising number of exploration studies have been completed to track down the use of hormone replacement therapy in COVID-19 contaminated patients. For example, according to the examination article distributed in BMC Medicine, 2020, the endurance rate in post-menopausal ladies tainted with SARS-CoV-2, who were on a standard portion of exogenous estradiol for post-menopausal grumblings, was viewed as high. Moreover, a stage 2 clinical preliminary was started by Stony Brook University in April 2020 to assess the job of estrogen in decreasing the seriousness of COVID-19 side effects contrasted with normal consideration, with the organization of estradiol through a transdermal fix for a brief span of 7 days. Subsequently, due to the previously mentioned factors, hormone replacement therapy is supposed to assume a promising part in creating novel therapeutics for the compelling therapy against SARS-CoV2 infection disease, which might prompt the development of the concentrated-on market during the pandemic.

The other prime drivers of hormone replacement therapy are expanded interest from regenerative prescriptions, for example, against maturing and conceptive cycle supporting therapy like menopausal hormone replacement. Rising interest in other restorative regions, for example, Growth Hormone Therapy and Thyroid Hormone Therapy because of nearly safe profile, proficiency, and cost viability of these medications is supposed to affect market development decidedly.

Also, new definitions, for example, transdermal medications, gels and creams that proposition advantages, for example, simplicity of medication organization and effect at area are supposed to build the development of hormone replacement therapy market during the estimate time frame. Benefits related with the hormone replacement therapy like decrease in risk rate of osteoporosis, cardiovascular sickness, and decrease of vasomotor side effects are additionally expected to support the development of hormone replacement therapy market before long. Hormone trade is suggested for renewing the hormones in the human body when the hormone levels in the body drop when contrasted with the standard levels expected for the legitimate working of the body.

Hormonal lopsidedness problems, including menopause, are the replacement therapy. The female body goes through a few kinds of hormonal changes. Hormone levels get adjusted with developing age, prompting different issues and sicknesses. Certain moves looked because of hormonal irregularity are weight gain, weakness, memory decline, low charisma, and muscle misfortune. Menopausal females are the main populace base affecting the market. The typical beginning period of menopause among ladies is around 45 to 50 years. In menopausal ladies, the hormonal degrees of progesterone and estrogen decline significantly.

Food and Drug Administration (FDA) has consented to an arrangement with NASEM (National Academies of Science, Engineering and Medicine) and is completing extended concurrences with University of Maryland and Johns Hopkins University Centers for Regulatory Science and Innovation. Primary concentration behind this drive was to direct research and illuminate customers with respect to intensified drugs.

NASEM is looking at the utility of treating people with intensified BHRT (Bioidentical Hormone Replacement Therapy) items. Intensified Bioidentical hormone replacement therapy items, for example, testosterone and progesterone are utilized rather than FDA supported hormone replacement therapy drugs as BHRT drugs are viewed as more protected and normal for patients. This component is probably going to affect the clinical preliminaries of new hormone replacement therapy items thusly testing the development of hormone replacement therapy market.

Report Scope of the Hormone Replacement Therapy Market

Report Coverage Details
Market Size by 2030 USD 53.9 Billion
Growth Rate from 2022 to 2030

CAGR of 14.13%

North America Market Share in 2021 40.50%
Menopause Indication Segment Market Share in 2021 48%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product, Route of Administration, Indication, Distribution Channel, Geography
Companies Mentioned Novo Nordisk A/S, Pfizer Inc., Endo International Plc, Allergen Plc, Janssen NV, Novartis AG, Bayer AG, Merck KGaA, Mithra Pharmaceuticals, Teva Pharmaceuticals, Mylan N.V, and Others

Product Insights

The estrogen hormone replacement therapy portion ruled the general market for hormone replacement therapy as far as income share in 2021. Estrogen replacement therapy is utilized in ladies during post-menopause or hysterectomy and assists them with keeping up with the hormonal equilibrium. Estrogen-based items have been contemplated to create the biggest number of solutions accordingly making it the biggest portion.

Human growth hormone therapy is supposed to observe the quickest development over the conjecture period attributable to the rising frequencies of development lacks, especially in newborn children. As per an overview coordinated by the WHO, around 15 million babies are conceived untimely and roughly 85% of these newborn children are not completely evolved. In grown-ups, the hormone therapy is accommodated conditions, for example, short gut disorder and pituitary tumors.

Hormone replacement therapy can safeguard memory which is expected to do transient mental assignments after menopausal pressure. Estrogen-just hormone replacement therapy can work with lower feelings of anxiety without affecting memory. Moreover, hormone replacement therapy additionally lessens potential outcomes of both vascular dementia and Alzheimer's sickness.

Utilization of hormone replacement therapy can prompt dangerous cell advancement. The utilization of combination hormone replacement therapy (mix of progesterone and estrogen) can build the gamble of bosom disease by 75% regardless of whether utilized for a short time period.

As indicated by the U.S Women's Health Initiative, the utilization of combination hormone supplanting therapy accompanies the gamble of advancement of a few diseases including ovarian malignant growth and uterus tumors. This viewpoint is supposed to restrict the development in reception of hormone replacement therapy in the impending years. Other hormone replacement therapy related problems, for example, stroke, cardiovascular issues and blood clusters are additionally expected to adversely affect the development of the hormone replacement therapy market.

Significant organizations in the hormone replacement therapy market are focusing on growing their ongoing item portfolio. New hormone replacement therapy definitions being the center concentration, organizations are doing preliminaries and gain FDA endorsements. Confidential value firms are centered around getting arising members that are engaged with drug conveyance frameworks in the hormone replacement therapy space.

Route of Administration Insights

On the foundations of the route of organization, the parenteral portion ruled the general market as far as income share in 2021. The oral route of organization is for the most part liked for testosterone drugs. The other fragment is comprehensive of items like vaginal creams, inserts, vaginal rings, and vaginal tablets.

Disease Insights

In the kind of illness fragment, menopause is supposed to be the quickest developing section over the gauge period from 2022 to 2030. As per the measurements given by the American Congress of Obstetricians and Gynecologists, around 6,000 ladies arrive at menopause every day.

The presence of different marked and nonexclusive medications and expanding mindfulness among ladies are expected to be the essential effect of delivering drivers. Rising number of ladies who are going to arrive at menopause and enlarging menopausal window from 40 to 55 years is driving the portion.

Indication Insights

Developing future is firmly connected with degeneration that further converts into osteoporotic breaks. Also, this condition further outcomes in an expansion in hole between spine bones during menopause with reducing estrogen levels.

Hormone Replacement Therapy Market Share, By Indication, 2021 (%)

As per the International Osteoporosis Foundation, osteoporosis causes over 8.9 million cracks every year on the worldwide front and is probably going to fill before long. Rising pervasiveness of osteoporosis among ladies is supposed to set off the interest for hormone replacement therapy.

Regional Insights

North America ruled the general market for hormone replacement therapy as far as income share in 2021. Calculates like advancement the medication conveyance frameworks, improvement of new details, and rising objective populace inside North America are supposed to keep up with its strength over the estimate period. The NIH expresses that portion of the postmenopausal ladies have utilized HRT something like once. Asia Pacific, then again, is supposed to observe the quickest development over the gauge period from 2022 to 2030. Expanding mindfulness levels and rising focal point of medical services suppliers on the destruction of hormonal lacks are supposed to help the development of the market inside the locale.

Hormone Replacement Therapy Market Share, By Region, 2021 (%)

Additionally, North America is having more market for Hormone Replacement Therapy. In North America, the U.S. addresses the biggest market as a result of expanding utilization of Hormone Replacement Therapy among patients matured 35 years and over. The accessibility of intensified drugs for example drugs in changed qualities, measurement structures, and so on - is a central point, which will in general lift the income development of this very famous therapy market. Beginning stage of maturing combined with rising extra cash levels are other significant elements fuelling market income development.

Asia district is supposed to have more development rate in forthcoming years due to expanding mindfulness about Hormone Replacement Therapy around here. In Asia locale India, China, Japan are supposed to have more development rate for Hormone Replacement Therapy.

Key Market Developments

  • Pfizer Inc. in 2022 finished the obtaining of Arena Pharmaceuticals. This obtaining will prompt upgrade in portfolio to dermatology, cardiology, gastroenterology and so forth.
  • Allergen Plc was procured by AbbVie in 2020. This obtaining is probably going to grow the portfolio to oncology, immunology, neuroscience and so forth.
  • Teva drugs has presented conventional form of Estrace cream and estradiol vaginal cream in 2018.
  • In December 2020, the US FDA supported the Myovant Sciences' Orgovyx (relugolix), which is an orally regulated therapy that works by hindering the pituitary organ from making hormones called luteinizing hormone and follicle-invigorating hormone, consequently prompting the decrease in how much testosterone created by the gonads. This guides in the therapy of grown-up patients with cutting edge prostate disease.

Some of the prominent players:

  • Novo Nordisk A/S
  • Pfizer Inc.
  • Endo International Plc
  • Allergen Plc
  • Janssen NV
  • Novartis AG
  • Bayer AG
  • Merck KGaA
  • Mithra Pharmaceuticals
  • Teva Pharmaceuticals
  • Mylan N.V
  • Other Market Players

Segments Covered in the Report

(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)

By Product

  • Oestrogen Hormone Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Hormone Replacement Therapy
  • Testosterone Hormone Replacement Therapy

By Route of Administration

  • Oral
  • Parenteral
  • Transdermal
  • Others

By Indication

  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others

By Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies & Stores
  • Online Pharmacies

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions

What is the current size of hormone replacement therapy market?
The global hormone replacement therapy market size was accounted at USD 31.4 billion in 2021 and it is expected to reach around USD 53.9 billion by 2030.
The global hormone replacement therapy market is poised to grow at a CAGR of 6.4% from 2022 to 2030.
The major players operating in the hormone replacement therapy market are Novo Nordisk A/S, Pfizer Inc., Endo International Plc, Allergen Plc, Janssen NV, Novartis AG, Bayer AG, Merck KGaA, Mithra Pharmaceuticals, Teva Pharmaceuticals, Mylan N.V, and Others
Extended interest from regenerative solutions, for instance, against developing and conceptive cycle supporting therapy like menopausal hormone replacement. Rising revenue in other helpful areas, for instance, Growth Hormone Therapy and Thyroid Hormone Therapy due to almost safe profile, capability, and cost suitability of these prescriptions should influence market improvement.
North America region will lead the global hormone replacement therapy market during the forecast period 2022 to 2030.
  • Report Code:1852
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Status:Published


   USD 4500
   USD 7000
   USD 9000


No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample